FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160516412> ?p ?o ?g. }

• W2160516412 endingPage "6673" @default.
• W2160516412 startingPage "6663" @default.
• W2160516412 abstract "To determine the safety, maximum tolerated dose, and pharmacokinetic-pharmacodynamic profile of a histone deacetylase inhibitor, LAQ824, in patients with advanced malignancy.LAQ824 was administered i.v. as a 3-h infusion on days 1, 2, and 3 every 21 days. Western blot assays of peripheral blood mononuclear cell lysates and tumor biopsies pretherapy and posttherapy evaluated target inhibition and effects on heat shock protein-90 (HSP90) client proteins and HSP72.Thirty-nine patients (22 male; median age, 53 years; median Eastern Cooperative Oncology Group performance status 1) were treated at seven dose levels (mg/m(2)): 6 (3 patients), 12 (4 patients), 24 (4 patients), 36 (4 patients), 48 (4 patients), 72 (19 patients), and 100 (1 patient). Dose-escalation used a modified continual reassessment method. Dose-limiting toxicities were transaminitis, fatigue, atrial fibrillation, raised serum creatinine, and hyperbilirubinemia. A patient with pancreatic cancer treated at 100 mg/m(2) died on course one at day 18 with grade 3 hyperbilirubinemia and neutropenia, fever, and acute renal failure. The area under the plasma concentration curve increased proportionally with increasing dose; median terminal half-life ranged from 8 to 14 hours. Peripheral blood mononuclear cell lysates showed consistent accumulation of acetylated histones posttherapy from 24 mg/m(2); higher doses resulted in increased and longer duration of pharmacodynamic effect. Changes in HSP90 client protein and HSP72 levels consistent with HSP90 inhibition were observed at higher doses. No objective response was documented; 3 patients had stable disease lasting up to 14 months. Based on these data, future efficacy trials should evaluate doses ranging from 24 to 72 mg/m(2).LAQ824 was well tolerated at doses that induced accumulation of histone acetylation, with higher doses inducing changes consistent with HSP90 inhibition." @default.
• W2160516412 created "2016-06-24" @default.
• W2160516412 creator A5003965204 @default.
• W2160516412 creator A5006946698 @default.
• W2160516412 creator A5011905014 @default.
• W2160516412 creator A5014804968 @default.
• W2160516412 creator A5018384442 @default.
• W2160516412 creator A5028833538 @default.
• W2160516412 creator A5029250422 @default.
• W2160516412 creator A5034625178 @default.
• W2160516412 creator A5051809103 @default.
• W2160516412 creator A5056423529 @default.
• W2160516412 creator A5060992997 @default.
• W2160516412 creator A5070570779 @default.
• W2160516412 creator A5072378199 @default.
• W2160516412 creator A5077479346 @default.
• W2160516412 creator A5088144652 @default.
• W2160516412 date "2008-10-15" @default.
• W2160516412 modified "2023-10-18" @default.
• W2160516412 title "Phase I Pharmacokinetic and Pharmacodynamic Study of LAQ824, a Hydroxamate Histone Deacetylase Inhibitor with a Heat Shock Protein-90 Inhibitory Profile, in Patients with Advanced Solid Tumors" @default.
• W2160516412 cites W1559282723 @default.
• W2160516412 cites W1665024321 @default.
• W2160516412 cites W1964290316 @default.
• W2160516412 cites W1967018540 @default.
• W2160516412 cites W1968568016 @default.
• W2160516412 cites W1969323007 @default.
• W2160516412 cites W1972149587 @default.
• W2160516412 cites W1978664410 @default.
• W2160516412 cites W1989051882 @default.
• W2160516412 cites W1994637279 @default.
• W2160516412 cites W1995683628 @default.
• W2160516412 cites W2002698073 @default.
• W2160516412 cites W2007276247 @default.
• W2160516412 cites W2008836678 @default.
• W2160516412 cites W2013571070 @default.
• W2160516412 cites W2023695795 @default.
• W2160516412 cites W2036720950 @default.
• W2160516412 cites W2054240721 @default.
• W2160516412 cites W2060181250 @default.
• W2160516412 cites W2072375912 @default.
• W2160516412 cites W2074280837 @default.
• W2160516412 cites W2076108528 @default.
• W2160516412 cites W2081973434 @default.
• W2160516412 cites W2084771218 @default.
• W2160516412 cites W2090906911 @default.
• W2160516412 cites W2099440961 @default.
• W2160516412 cites W2101402339 @default.
• W2160516412 cites W2104022826 @default.
• W2160516412 cites W2108230631 @default.
• W2160516412 cites W2110787699 @default.
• W2160516412 cites W2111187586 @default.
• W2160516412 cites W2112351720 @default.
• W2160516412 cites W2112417555 @default.
• W2160516412 cites W2132677196 @default.
• W2160516412 cites W2143658931 @default.
• W2160516412 cites W2148471976 @default.
• W2160516412 cites W2149386327 @default.
• W2160516412 cites W2151016906 @default.
• W2160516412 cites W2151445954 @default.
• W2160516412 cites W2157401351 @default.
• W2160516412 cites W2158740848 @default.
• W2160516412 cites W2162934657 @default.
• W2160516412 cites W2168968323 @default.
• W2160516412 cites W2171074974 @default.
• W2160516412 cites W2600059637 @default.
• W2160516412 cites W4230677464 @default.
• W2160516412 doi "https://doi.org/10.1158/1078-0432.ccr-08-0376" @default.
• W2160516412 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18927309" @default.
• W2160516412 hasPublicationYear "2008" @default.
• W2160516412 type Work @default.
• W2160516412 sameAs 2160516412 @default.
• W2160516412 citedByCount "102" @default.
• W2160516412 countsByYear W21605164122012 @default.
• W2160516412 countsByYear W21605164122013 @default.
• W2160516412 countsByYear W21605164122014 @default.
• W2160516412 countsByYear W21605164122015 @default.
• W2160516412 countsByYear W21605164122016 @default.
• W2160516412 countsByYear W21605164122017 @default.
• W2160516412 countsByYear W21605164122018 @default.
• W2160516412 countsByYear W21605164122019 @default.
• W2160516412 countsByYear W21605164122020 @default.
• W2160516412 countsByYear W21605164122021 @default.
• W2160516412 countsByYear W21605164122022 @default.
• W2160516412 countsByYear W21605164122023 @default.
• W2160516412 crossrefType "journal-article" @default.
• W2160516412 hasAuthorship W2160516412A5003965204 @default.
• W2160516412 hasAuthorship W2160516412A5006946698 @default.
• W2160516412 hasAuthorship W2160516412A5011905014 @default.
• W2160516412 hasAuthorship W2160516412A5014804968 @default.
• W2160516412 hasAuthorship W2160516412A5018384442 @default.
• W2160516412 hasAuthorship W2160516412A5028833538 @default.
• W2160516412 hasAuthorship W2160516412A5029250422 @default.
• W2160516412 hasAuthorship W2160516412A5034625178 @default.
• W2160516412 hasAuthorship W2160516412A5051809103 @default.
• W2160516412 hasAuthorship W2160516412A5056423529 @default.
• W2160516412 hasAuthorship W2160516412A5060992997 @default.
• W2160516412 hasAuthorship W2160516412A5070570779 @default.
• W2160516412 hasAuthorship W2160516412A5072378199 @default.

• next